The present proposal is a pilot study designed to test the feasibility of a future project to be conducted in a multicenter trial in hospitalized patients, to determine the tolerance of roflumilast in hospitalized COPD patients, and to determine the treatment effect of roflumilast to decrease all-cause mortality and all cause readmission rate as add-on therapy. The specifics aims will be: